Eevia Health secures an 868 KSEK sales order from a new customer for a new superior polyphenol extract

Eevia Health Plc (”Eevia” or ”The Company”) has won a 77 KEUR (868 KSEK) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Cerasus™ 50 Organic, a new tart cherry extract product with the highest concentration of polyphenols when  compared to competitive Tart Cherry extracts.

The end customer, a North American brand owner headquartered in the Mid-West US, is a fast-growing brand dedicated to organic, clean ingredients in its consumer products. They market dietary supplements and health foods across the US through different channels and outlets, including direct sales. The new customer is a significant market opportunity for Eevia Health.

Select Ingredients, a distributor of Eevia Health located in California, USA, made the sale. Select has a strong presence in the organic ingredients sector of the nutraceutical industry.

The new order's sales value to Eevia is c. 77 KEUR for Feno-Cerasus™ 50 Organic. This extract made from organic tart cherries is standardized to a minimum of 50 % polyphenols and 7% anthocyanins, the highest concentration in the market. The order is the first commercial-size order for Eevia’s cherry extract.

Tart Cherry anthocyanins and polyphenols have scientifically proven effects on human memory, concentration, and sleep quality, making them a compelling choice for health-conscious consumers. Eevia Health manufactures this extract with a superior purification technology compared to competitors, providing more than twice the bioactive concentration of what other manufacturers offer as well as a broader spectrum of polyphenols.

"First-order sales of new products are milestones. It is a significant start sale for our tart cherry product, which we expect will open the gates for other brands. It is a long-sought win with an extremely fastidious customer. The customer is excited about the quality and strength of this product. One can see the difference in quality from competitor’s products with the naked eye – our product's dark, vibrant red color exudes potency," says Erik Eide, Commercial Director of Eevia Health, expressing the company's success and enthusiasm.

 

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]  or [email protected]                     

Telephone: +358 400 22 5967                         

 

 

 

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.

Eevia Health manufactures 100% organically certified plant extracts. Our commitment to sustainable and organic manufacturing practices, such as wild-harvesting our raw materials and operating a modern green chemistry production facility, ensures the highest quality products for our customers.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.